These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32762663)

  • 1. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol.
    Maier A; Dharan A; Oliver G; Berk M; Redston S; Back SE; Kalivas P; Ng C; Kanaan RA
    BMC Psychiatry; 2020 Aug; 20(1):397. PubMed ID: 32762663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD.
    Kanaan RA; Oliver G; Dharan A; Sendi S; Maier A; Mohebbi M; Ng C; Back SE; Kalivas P; Berk M
    Psychiatry Res; 2023 Sep; 327():115398. PubMed ID: 37540942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M
    Trials; 2019 Jun; 20(1):325. PubMed ID: 31164169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
    Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
    J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo.
    Berk M; Turner A; Malhi GS; Ng CH; Cotton SM; Dodd S; Samuni Y; Tanious M; McAulay C; Dowling N; Sarris J; Owen L; Waterdrinker A; Smith D; Dean OM
    BMC Med; 2019 Jan; 17(1):18. PubMed ID: 30678686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.
    Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS
    J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms.
    Rossell SL; Francis PS; Galletly C; Harris A; Siskind D; Berk M; Bozaoglu K; Dark F; Dean O; Liu D; Meyer D; Neill E; Phillipou A; Sarris J; Castle DJ
    BMC Psychiatry; 2016 Sep; 16(1):320. PubMed ID: 27629871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis.
    Cotton SM; Berk M; Watson A; Wood S; Allott K; Bartholomeusz CF; Bortolasci CC; Walder K; O'Donoghue B; Dean OM; Chanen A; Amminger GP; McGorry PD; Burnside A; Uren J; Ratheesh A; Dodd S
    Trials; 2019 Nov; 20(1):658. PubMed ID: 31779696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.
    Krystal JH; Rosenheck RA; Cramer JA; Vessicchio JC; Jones KM; Vertrees JE; Horney RA; Huang GD; Stock C;
    JAMA; 2011 Aug; 306(5):493-502. PubMed ID: 21813427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment.
    Naylor JC; Kilts JD; Bradford DW; Strauss JL; Capehart BP; Szabo ST; Smith KD; Dunn CE; Conner KM; Davidson JR; Wagner HR; Hamer RM; Marx CE
    Int Clin Psychopharmacol; 2015 May; 30(3):167-74. PubMed ID: 25647451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial.
    Back SE; Gray K; Santa Ana E; Jones JL; Jarnecke AM; Joseph JE; Prisciandaro J; Killeen T; Brown DG; Taimina L; Compean E; Malcolm R; Flanagan JC; Kalivas PW
    Contemp Clin Trials; 2020 Apr; 91():105961. PubMed ID: 32087337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.
    Sarris J; Byrne G; Castle D; Bousman C; Oliver G; Cribb L; Blair-West S; Brakoulias V; Camfield D; Ee C; Chamoli S; Boschen M; Dean OM; Dowling N; Menon R; Murphy J; Metri NJ; Nguyen TP; Wong A; Jordan R; Karamacoska D; Rossell SL; Berk M; Ng CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jul; 117():110550. PubMed ID: 35304155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
    Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA
    Mol Autism; 2016; 7():26. PubMed ID: 27103982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
    Sarris J; Oliver G; Camfield DA; Dean OM; Dowling N; Smith DJ; Murphy J; Menon R; Berk M; Blair-West S; Ng CH
    CNS Drugs; 2015 Sep; 29(9):801-9. PubMed ID: 26374743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
    Ellegaard PK; Licht RW; Nielsen RE; Dean OM; Berk M; Poulsen HE; Mohebbi M; Nielsen CT
    J Affect Disord; 2019 Feb; 245():1043-1051. PubMed ID: 30699846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
    Bauer IE; Green C; Colpo GD; Teixeira AL; Selvaraj S; Durkin K; Zunta-Soares GB; Soares JC
    J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30549489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pragmatic RAndomised controlled trial of a trauma-focused guided self-help Programme versus InDividual trauma-focused cognitive Behavioural therapy for post-traumatic stress disorder (RAPID): trial protocol.
    Nollett C; Lewis C; Kitchiner N; Roberts N; Addison K; Brookes-Howell L; Cosgrove S; Cullen K; Ehlers A; Heke S; Kelson M; Lovell K; Madden K; McEwan K; McNamara R; Phillips C; Pickles T; Simon N; Bisson J
    BMC Psychiatry; 2018 Mar; 18(1):77. PubMed ID: 29580220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol).
    Ellegaard PK; Licht RW; Poulsen HE; Nielsen RE; Berk M; Dean OM; Mohebbi M; Nielsen CT
    Int J Bipolar Disord; 2018 Apr; 6(1):11. PubMed ID: 29619634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial.
    Liao Y; Wu Y; Zi K; Shen Y; Wang T; Qin J; Chen L; Chen M; Liu L; Li W; Zhou H; Xiong S; Wen F; Chen J
    BMC Pulm Med; 2022 Nov; 22(1):401. PubMed ID: 36344940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.